Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov;94(11):5086-5087.
doi: 10.1002/jmv.27999. Epub 2022 Jul 18.

In response to: Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study

Affiliations
Comment

In response to: Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study

Luigi Angelo Vaira et al. J Med Virol. 2022 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment in

Comment on

References

    1. Mercier J, Osman M, Bouiller K, et al. Olfactory dysfunction in COVID‐19, new insights from a cohort of 353 patients: the ANOSVID study. J Med Virol. 2022;:. 10.1002/jmv.27918 - DOI - PMC - PubMed
    1. Boscolo‐Rizzo P, Hummel T, Hopkins C, et al. High prevalence of long‐term olfactory, gustatory, and chemesthesis dysfunction in post‐COVID‐19 patients: a matched case‐control study with one‐year follow‐up using a comprehensive psychophysical evaluation. Rhinology. 2021;59:517‐527. - PubMed
    1. Hannum ME, Ramirez VA, Lipson SJ, et al. Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID‐19‐positive patients compared to subjective methods: a systematic review and meta‐analysis. Chem Senses. 2020;45:865‐74. - PMC - PubMed
    1. Vaira LA, Hopkins C, Petrocelli M, et al. Do olfactory and gustatory pshychophysical scores have prognostic value in COVID‐19 patients? A prospective study of 106 patients. J Otolaryngol Head Neck Sur. 2020;49:56. - PMC - PubMed
    1. Killingley B, Mann AJ, Kalinova M, et al. Safety, tolerability and viral kinetics during SARS‐CoV‐2 human challenge in young adults. Nat Med. 2022;28:1031‐1041. - PubMed